HOUSTON – (July 13, 2022) – Vaccines may need to dig a little deeper to stop SARS-CoV-2. Rice University researchers are providing a new shovel.
The lab of computer scientist Lydia Kavraki at Rice’s George R. Brown School of Engineering has introduced a program to look for conserved parts of proteins of the virus that causes COVID-19. These parts could help develop future vaccines.
The lab’s open-source program, SARS-Arena, identifies peptides that are part of the virus’s nucleocapsid protein to see how they could be targeted. Kavraki said the program was designed from the outset to be highly customizable and easy to use.
“Our work does not analyze the surface spike proteins of SARS-related coronaviruses but a protein deep inside the core of such viruses,” Kavraki said. “We define and systematize a complex process of discovering fragments of that protein that can serve as a basis for the development of novel vaccines.”
The program builds upon the lab’s established HLA-Arena, a customizable pipeline for structural modeling and analysis of complexes formed by peptides – small parts of proteins – and human leukocyte antigen (HLA) receptors, central to the cellular immunity.
SARS-CoV-2 nucleocapsid protein is compact and hidden within the SARS shell, where it helps in viral genome packaging. The protein is highly conserved across SARS viruses, and because it is located in the inner part of the virus, it is also less subject to mutation than proteins along the surface envelope, especially the spike protein targeted by most current COVID vaccines.
Surface proteins are a moving target for vaccines, said lead author and postdoctoral researcher Mauricio Menegatti Rigo. The omicron variant has more than 30 mutations in the spike protein alone, and that has probably contributed to its rapid infection rate.
Nucleocapsid proteins are highly expressed upon infection. That also increases opportunities for the immune system to spot them and move in. Nucleocapsids are highly immunogenic, making them likely to provoke an immune response.
But not all of the well-conserved peptide “hooks” within the nucleocapsid are known, nor is there sufficient data on how they bind to HLAs. Identifying more of them could aid the search for broad-spectrum, long-lasting coronavirusvaccines, Rigo said.
“We are mostly interested in the cellular immune response triggered against nucleocapsid peptides,” he said. “So the first part of the paper is about identifying these conserved peptides. In the second part, we provide a way to analyze not only the sequence of the peptides but also how they could bind to HLA molecules.
“Then we can look for clues about how the peptides are presented in the context of the immune response,” Rigo said. “We show that through structural analysis, we can identify cross-reactive peptides and also similar peptides that are potentially cross-reactive. These similar peptides that are not described in the literature are putative new targets for vaccines.”
There are studies showing that immune-system T-cells taken from recovered COVID-19 patients can recognize multiple regions of the nucleocapsid protein, providing long-term protective immunity. So finding peptide targets within the nucleocapsid became a worthy goal, Rigo said.
The new work is a continuation of efforts by the Rice team to simplify the search for coronavirus vaccines. In a November 2020 paper published in the Proceedings of the National Academy of Sciences, the researchers identified a SARS-CoV-2 peptide that affects binding stability with an immune system receptor, influencing a body’s ability to attack diseased cells. Another paper published in June by Nature’s Scientific Reports improves upon their algorithm to predict binding affinity between peptide structures and HLAs. That study has implications for the development of both virus and cancer vaccines.
Rice alumnus Dinler Amaral Antunes, now an assistant professor of computational biology at the University of Houston, is co-corresponding author of the paper. Co-authors are Rice graduate students Romanos Fasoulis, Anja Conev and Sarah Hall-Swan. Kavraki is the Noah Harding Professor of Computer Science and a professor of bioengineering, mechanical engineering and electrical and computer engineering, and director of the Ken Kennedy Institute.
The National Science Foundation (2033262), the Cancer Prevention and Research Institute of Texas (RP170593), a National Library of Medicine Training Program fellowship (T15LM007093-29) and the National Institutes of Health (U01CA258512) supported the research.
Read the abstract at https://www.frontiersin.org/articles/10.3389/fimmu.2022.931155/abstract.
This news release can be found online at https://news.rice.edu/news/2022/sars-arena-reveals-hidden-hooks-virus.
Follow Rice News and Media Relations via Twitter @RiceUNews.
Rice web server helps identify COVID-19 drug candidates: https://news.rice.edu/news/2021/rice-web-server-helps-identify-covid-19-drug-candidates
Once-discounted binding mechanism may be key to targeting viruses: https://news.rice.edu/news/2020/once-discounted-binding-mechanism-may-be-key-targeting-viruses
Kavraki Lab: https://www.kavrakilab.org
Department of Computer Science: https://csweb.rice.edu
George R. Brown School of Engineering: https://engineering.rice.edu
Images for download:
Rice University computer scientists have developed SARS-Arena to help find conserved parts in proteins from SARS-CoV-2 that could be a key for the development of wide-spectrum vaccines. The program searches for potential matches between regions in nucleocapsid (N) proteins and human leukocyte antigen (HLA) receptors that are central to cellular immunity. (Credit: Illustration by Mauricio Menegatti Rigo/Rice University)
Rice University graduate students, from left, Anja Conev, Romanos Fasoulis and Sarah Hall-Swan and postdoctoral researcher Mauricio Menegatti Rigo worked on the development of SARS-Arena, a program that helps find conserved parts in proteins from SARS-CoV-2 that could be a key for the development of wide-spectrum vaccines. (Credit: Rice University)
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 4,240 undergraduates and 3,972 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 1 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance.
Frontiers in Immunology
Method of Research
Subject of Research
SARS-Arena: Sequence and Structure-Guided Selection of Conserved Peptides from SARS-related Coronaviruses for Novel Vaccine Development
Article Publication Date
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.